BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 37366802)

  • 41. Correlation of interferon-lambda 4 ss469415590 with the hepatitis C virus treatment response and its comparison with interleukin 28b polymorphisms in predicting a sustained virological response: a meta-analysis.
    Li Y; Yang L; Sha K; Liu T; Zhang L
    Int J Infect Dis; 2016 Dec; 53():52-58. PubMed ID: 27810523
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The
    Zhou H; Møhlenberg M; Terczyńska-Dyla E; Winther KG; Hansen NH; Vad-Nielsen J; Laloli L; Dijkman R; Nielsen AL; Gad HH; Hartmann R
    J Virol; 2020 Feb; 94(5):. PubMed ID: 31776283
    [TBL] [Abstract][Full Text] [Related]  

  • 43. IFNL4 polymorphism predicts response to hepatitis C treatment after liver transplantation.
    Fernández-Carrillo C; Coto-Llerena M; González P; Crespo G; Mensa L; Caro-Pérez N; Gambato M; Navasa M; Forns X; Pérez-del-Pulgar S
    J Clin Virol; 2014 Oct; 61(2):282-5. PubMed ID: 25130512
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of donor IFNL4 genotype and non-relapse mortality after unrelated donor myeloablative haematopoietic stem-cell transplantation for acute leukaemia: a retrospective cohort study.
    Gadalla SM; Wang Y; Wang T; Onabajo OO; Banday AR; Obajemu A; Karaesman E; Sucheston-Campbell L; Hahn T; Sees JA; Spellman SR; Lee SJ; Katki HA; Prokunina-Olsson L
    Lancet Haematol; 2020 Oct; 7(10):e715-e723. PubMed ID: 32976751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and
    Liao HM; Liu H; Chin PJ; Li B; Hung GC; Tsai S; Otim I; Legason ID; Ogwang MD; Reynolds SJ; Kerchan P; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Ayers LW; Pfeiffer RM; Bhatia K; Goedert JJ; Lo SC; Mbulaiteye SM
    Front Oncol; 2022; 12():812224. PubMed ID: 35340265
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interferon lambda 4 rs368234815 TT>δG variant is associated with liver damage in patients with nonalcoholic fatty liver disease.
    Petta S; Valenti L; Tuttolomondo A; Dongiovanni P; Pipitone RM; Cammà C; Cabibi D; Di Marco V; Fracanzani AL; Badiali S; Nobili V; Fargion S; Grimaudo S; Craxì A
    Hepatology; 2017 Dec; 66(6):1885-1893. PubMed ID: 28741298
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Impact of virus subtype and host
    Simmonds P; Cuypers L; Irving WL; McLauchlan J; Cooke GS; Barnes E; ; Ansari MA
    RNA; 2020 Nov; 26(11):1541-1556. PubMed ID: 32747607
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
    Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
    Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occult hepatitis C virus infection in hemophilia patients and its correlation with interferon lambda 3 and 4 polymorphisms.
    Nafari AH; Ayadi A; Noormohamadi Z; Sakhaee F; Vaziri F; Siadat SD; Fateh A
    Infect Genet Evol; 2020 Apr; 79():104144. PubMed ID: 31838260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
    Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
    PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High-resolution melting assay for genotyping of IFNL4-associated dinucleotide variant rs368234815.
    Galmozzi E; Facchetti F; Perbellini R; Aghemo A
    Clin Microbiol Infect; 2014 Nov; 20(11):O936-8. PubMed ID: 24724563
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses.
    Grzegorzewska AE
    Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genetics of the Human Interferon Lambda Region.
    Prokunina-Olsson L
    J Interferon Cytokine Res; 2019 Oct; 39(10):599-608. PubMed ID: 31070498
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Its all about IFN-λ4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
    Matic S; Milovanovic D; Mijailovic Z; Djurdjevic P; Sazdanovic P; Stefanovic S; Todorovic D; Popovic S; Vitosevic K; Vukicevic V; Vukic M; Vukovic N; Milivojevic N; Zivanovic M; Jakovljevic V; Filipovic N; Djordjevic N; Baskic D
    J Med Virol; 2023 Oct; 95(10):e29152. PubMed ID: 37812032
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The interferon lambda 4 rs368234815 predicts treatment response to pegylated-interferon alpha and ribavirin in hemophilic patients with chronic hepatitis C.
    Keshvari M; Alavian SM; Behnava B; Pouryasin A; Sharafi H
    J Res Med Sci; 2016; 21():72. PubMed ID: 27904617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-Analysis.
    Wu Q; Wang C; Chen EQ; Tang H; Li ZZ; Lei XZ
    Hepat Mon; 2015 Dec; 15(12):e32707. PubMed ID: 26977165
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Impact of
    Pedergnana V; Irving WL; Barnes E; McLauchlan J; Spencer CCA
    J Interferon Cytokine Res; 2019 Oct; 39(10):642-649. PubMed ID: 31260374
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Simple PCR-RFLP Method for Genotyping of IFNL4 rs368234815 Polymorphism in Patients With Chronic Hepatitis C.
    Pouryasin M; Sharafi H; Behnava B; Alavian SM; Keshvari M; Pouryasin A
    Lab Med; 2017 Feb; 48(1):51-56. PubMed ID: 28057801
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians.
    Knapp S; Zakaria Z; Hashem M; Zaghla H; Khakoo SI; Waked I; Thursz M; Abdelwahab SF
    Hepatol Int; 2015 Apr; 9(2):251-7. PubMed ID: 25788203
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.